| Mr Christopher Arthur Post, MD | |
|
1250 Hancock St, Quincy, MA 02169-4339 | |
| (617) 774-0840 | |
| Not Available |
| Full Name | Mr Christopher Arthur Post |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 1250 Hancock St, Quincy, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851474951 | NPI | - | NPPES |
| 3681659 | Other | CIGNA | |
| 2218272 | Other | UNITED HEALTH CARE | |
| 89132GP | Medicaid | NC | |
| 180373 | Other | WELL PATH | |
| 80187618 | Other | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 234250 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Christopher Arthur Post, MD 1250 Hancock St, Quincy, MA 02169-4339 Ph: (617) 774-0840 | Mr Christopher Arthur Post, MD 1250 Hancock St, Quincy, MA 02169-4339 Ph: (617) 774-0840 |
News Archive
The British Pharmacological Society proudly announces that its first annual Drug Discovery of the Year award has been won by the discovery team developing vismodegib for the treatment of basal cell carcinoma (a type of skin cancer).
University of California San Diego was awarded five Rapid Acceleration of Diagnostics (RADx) projects by the National Institutes of Health, totaling nearly $33 million over four years.
Purdue Pharma L.P. announced today that the U.S. Food and Drug Administration (FDA) approved Butrans™ (buprenorphine) Transdermal System CIII for the management of moderate to severe chronic pain in patients requiring a continuous, around-the-clock opioid analgesic for an extended period of time. Butrans Transdermal System is an analgesic product that delivers continuous release of medication for seven days.
Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc., today announced that it has completed enrollment of its ADVANCE-PD trial. ADVANCE-PD is a multinational Phase III trial of its late-stage product IPX066 in advanced Parkinson's disease (PD) patients with motor fluctuations. IPX066 is an investigational extended release carbidopa-levodopa product intended to rapidly achieve and sustain effective blood concentrations of levodopa, potentially improving PD clinical symptom management.
› Verified 7 days ago
Roger Lu, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1690 Crown Colony Dr, Quincy, MA 02169 Phone: 857-403-4600 | |
John Loughnane, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 205 Parkingway, Quincy, MA 02169 Phone: 617-820-5968 Fax: 833-471-5603 | |
Sergio Ramoa, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1250 Hancock St, Quincy, MA 02169 Phone: 617-774-0840 Fax: 617-774-0882 | |
Dr. Rita P Wadhwani, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 114 Whitwell St, 2 Nd Floor B Wing, Quincy, MA 02169 Phone: 617-376-3000 Fax: 617-774-1906 | |
Obli Chetty Maragatha Mani, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1250 Hancock St, Internal Medicine, Quincy, MA 02169 Phone: 617-774-0840 Fax: 617-774-0882 | |
Jee Chung Lin, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1250 Hancock St, Quincy, MA 02169 Phone: 617-774-0840 | |
Dr. Natalie Catherine Morson, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 110 W Squantum St, Quincy, MA 02171 Phone: 617-376-3000 |